1-Bromo-4-methoxy-2-methyl-5-nitrobenzene, 95.0%, 5g

tert-Butyl 1-chloro-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, 98%, 1g

1-Allylindoline-2,3-dione, 95.0%, 250mg

Potassium Acetate, 99%, 500g

5-Chloro-pyridine-2,3-dicarboxylic acid, 96%, 250mg

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 98%, 250mg

1-((Benzyloxy)carbonyl)-3-((tert-butoxycarbonyl)amino)piperidine-3-carboxylic acid, 95.0%, 5g

(2r)-2-(4-Chloro-2-methylphenoxy)propanoic acid, 98%, 50mg

1-Allyl-5-methyl-1H-pyrazole-4-carbaldehyde, 95.0%, 10g

2-(2,6-Difluoro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

2-Amino-5-bromo-3-methoxypyrazine>99.0%(GC)(T)1g

4-Chloro-2-(methylamino)benzoic acid, 95.0%, 10g

Sodium hydroxide solution, ROTI® volume 0.1 mol/l - 0.1 N, ampoule, 1 piece, plastic packaging.